International Stem Cell CORP
ISCO· OTC
Released Nov 13, 2013, before the open
10-Q filed Nov 13, 2013, 44 days after period end · 0001193125-13-439222
| Metric | Q3 2013 | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|---|
| Revenue | $1.67M | $1.19M | $842.00K | $348.98K |
| Net Income | -$3.80M | -$2.08M | -$2.57M | -$3.02M |
| EPS Diluted |
International Stem Cell CORP · CIK 1355790 · Engraved from SEC EDGAR
| -$0.03 |
| -$0.02 |
| -$0.03 |
| -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.